Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)
Clinical trial NCT05838092 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05838092
- Sponsor
- RHEACELL GmbH & Co. KG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2025-08-29
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.